These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24225043)

  • 21. Thyroid dysfunction in drug reaction with eosinophilia and systemic symptoms (DRESS): an unusual manifestation of systemic drug hypersensitivity.
    Cookson H; Creamer D; Walsh S
    Br J Dermatol; 2013 May; 168(5):1130-2. PubMed ID: 23614562
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.
    Adwan MH
    Curr Rheumatol Rep; 2017 Jan; 19(1):3. PubMed ID: 28138822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine.
    Rosenbaum J; Alex G; Roberts H; Orchard D
    J Paediatr Child Health; 2010 Apr; 46(4):193-6. PubMed ID: 20546480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual neurological and cardiac complications of drug reaction with eosinophilia and systemic symptoms syndrome: a case report.
    Khellaf L; Cosserat J; Calas A; Brasme H; Charles P
    Eur J Dermatol; 2021 Oct; 31(5):652-654. PubMed ID: 34789449
    [No Abstract]   [Full Text] [Related]  

  • 25. Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo.
    Lian BS; Busmanis I; Lee HY
    Ann Acad Med Singap; 2018 Nov; 47(11):492-493. PubMed ID: 30578426
    [No Abstract]   [Full Text] [Related]  

  • 26. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DRESS syndrome triple whammy: sulfasalazine, amoxicillin and HHV-7.
    Lang M; Fish J; Covelli C; Schreiber BE
    Br J Hosp Med (Lond); 2017 Nov; 78(11):648-649. PubMed ID: 29111803
    [No Abstract]   [Full Text] [Related]  

  • 28. Severe acute hepatitis induced by a DRESS syndrome to piroxicam.
    Bizid S; Haddad W; Ben Abdallah H; Ghanem M; Bouali R; Abdelli N
    Tunis Med; 2014 Jun; 92(6):417. PubMed ID: 25741844
    [No Abstract]   [Full Text] [Related]  

  • 29. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
    Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of sulfasalazine in the treatment of generalized lichen planus: randomized double-blinded clinical trial on 52 patients.
    Omidian M; Ayoobi A; Mapar MA; Feily A; Cheraghian B
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1051-4. PubMed ID: 20158586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salazosulfapyridine induced hypersensitivity syndrome associated with reactivation of humanherpes virus 6.
    Kunisaki Y; Goto H; Kitagawa K; Nagano M
    Intern Med; 2003 Feb; 42(2):203-7. PubMed ID: 12636244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmachem's salazopyrine in rheumatoid arthritis].
    Konstantinova M; Konstantinova V
    Vutr Boles; 1990; 29(5):65-8. PubMed ID: 1981958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two cases of tuberculosis with multiple drug hypersensitivity after drug-induced hypersensitivity syndrome.
    Sekine A; Saito T; Ito S; Tsunoda Y; Sumazaki Y; Tanaka T; Takoi H; Lin SY; Yatagai Y; Hayasihara K
    Respir Investig; 2012 Jun; 50(2):70-5. PubMed ID: 22749254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfasalazine-induced aseptic meningitis with positive rechallenge: a case report and review of the literature.
    Salouage I; El Aïdli S; Cherif F; Kastalli S; Zaiem A; Daghfous R
    Therapie; 2013; 68(6):423-6. PubMed ID: 24356191
    [No Abstract]   [Full Text] [Related]  

  • 36. A 63-year-old returned traveller with fever, rash, hepatitis and eosinophilia.
    Jeimy S; McRae K; Pattani R
    CMAJ; 2018 Jul; 190(27):E831-E835. PubMed ID: 29986859
    [No Abstract]   [Full Text] [Related]  

  • 37. Is p-phenylenediamine a marker of sulfasalazine allergy?
    Kenani Z; Lahouel I; Belhadjali H; Soua Y; Aouam K; Youssef M; Zili J
    Contact Dermatitis; 2018 Feb; 78(2):173-174. PubMed ID: 29341189
    [No Abstract]   [Full Text] [Related]  

  • 38. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489
    [No Abstract]   [Full Text] [Related]  

  • 39. [DRESS syndrome following sulfasalazine treatment].
    Pirklbauer M; Gruber J
    Z Rheumatol; 2014 Mar; 73(2):180-3. PubMed ID: 24337150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The treatment of rheumatoid polyarthritis using salazosulfapyridine (Salazopyrine). A 6-month open study of 34 patients].
    Ghozlan R; Dupuis M; Schwak A; Jorro P; Lecarpentier C; Guillon C
    Rev Rhum Mal Osteoartic; 1988 Feb; 55(2):127-30. PubMed ID: 2895959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.